HIGHLIGHTS
- who: MDPI from the Medical Oncology Department, Hospital Clinic i Provincial de Barcelona, Barcelona, Spain , Medicine Department, University of Barcelona, Barcelona, Spain have published the paper: Immune‐Related Uncommon Adverse Events in Patients with Cancer Treated with Immunotherapy, in the Journal: Diagnostics 2022, 12, 2091. of /2022/
SUMMARY
Immunotherapy has changed the therapeutic landscape in oncology. Nev‐ ertheless, ICI have brought a completely new spectrum of side effects, commonly referred as immune‐related adverse reactions (irAEs). The use of ICI combinations (i.e., anti‐PD(L)‐1 and anti‐CTLA‐4 an‐ tibodies . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.